| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 03/17/2009 | US7504098 Method for introducing a biological molecule using a viral envelope and heparin and system therefore |
| 03/17/2009 | US7503913 Methods and compositions for use in perfusion applications |
| 03/17/2009 | US7503889 Apparatus for the continuous separation of biological fluids into components and method of using same |
| 03/13/2009 | CA2630708A1 Method of isolation and use of cells derived from first trimester umbilical cord tissue |
| 03/12/2009 | WO2009032888A2 Method for providing energy, relieving stress and mood enhancing benefits comprising administering a composition comprising cholecalciferol and a tea extract |
| 03/12/2009 | WO2009032887A1 Methods of treating or preventing respiratory tract infection comprising administering cholecalciferol |
| 03/12/2009 | WO2009032774A2 Hotel rate analytic system |
| 03/12/2009 | WO2009032320A1 Cell composition for tissue regeneration |
| 03/12/2009 | WO2009031970A1 Composition for separating spermatozoa from a semen sample |
| 03/12/2009 | WO2009031635A1 Recombinant vector for treatment of nephrogenic diabetes insipidus, and use thereof |
| 03/12/2009 | WO2009031606A1 Therapeutic and prophylactic agents for arthritis |
| 03/12/2009 | WO2009031333A1 Medium for insects belonging to sarcophagidae and calliphoridae in the ovary development stage and egg laying stage, method of feeding insects belonging to sarcophagidae and calliphoridae and insects for medical use |
| 03/12/2009 | WO2009031106A2 Use of a combination of hesperidin and of a microorganism for influencing the barrier function of the skin |
| 03/12/2009 | WO2009031099A2 Cosmetic use of microorganisms |
| 03/12/2009 | WO2009030092A1 Culture medium and method for in vitro culturing human adult primary mesenchymal stem cells on a large scale, primary mesenchymal stem cells obtained by the method, the uses thereof |
| 03/12/2009 | WO2009030040A1 Antimicrobial activity of bacteriocin-producing lactic acid bacteria |
| 03/12/2009 | WO2009030025A1 Porcine adeno-associated viruses |
| 03/12/2009 | WO2009010885A3 Use of cd200 as a mesenchymal stem cells marker |
| 03/12/2009 | WO2008146133A3 Hematopoietic cells that express mosc-1 |
| 03/12/2009 | WO2007138621A8 Pharmaceutical use of protein molecules immunologically correlated to diphtheria toxin |
| 03/12/2009 | US20090069258 Recombinant antibodies specific for beta-amyloid ends, dna encoding and methods of use thereof |
| 03/12/2009 | US20090069246 Methods for promoting hematopoietic and mesenchymal cell proliferation and differentiation |
| 03/12/2009 | US20090069240 Method of preventing and treating endocrine system disturbances |
| 03/12/2009 | US20090068745 Compositions and methods for performing reverse gene therapy |
| 03/12/2009 | US20090068734 Human salivary gland-origin stem cell |
| 03/12/2009 | US20090068289 Formulation for menopausal women |
| 03/12/2009 | US20090068281 Composition, Functional Food and Pharmaceutical Composition for Improvement in Obesity |
| 03/12/2009 | US20090068270 Treatment of degenerated disc with autologous cells |
| 03/12/2009 | US20090068230 Enterohemorrhagic escherichia coli vaccine |
| 03/12/2009 | US20090068229 Modified surface antigen |
| 03/12/2009 | US20090068227 Use of neurotoxin therapy for treatment of urologic and related disorders |
| 03/12/2009 | US20090068216 Modified surface antigen |
| 03/12/2009 | US20090068193 Treatment And Prophylaxis With 4-1BB-Binding Agents |
| 03/12/2009 | US20090068189 Monoclonal Antibody to Human TGF-Beta Induced Gene-H3 and Use Thereof |
| 03/12/2009 | US20090068169 2,4,6-triamino-s-triazine-based compounds which bind to the tail (fc) portion of immunoglobulins and their use |
| 03/12/2009 | US20090068161 Use of a combination of hesperidin and of a microorganism for influencing the barrier function of the skin |
| 03/12/2009 | US20090068160 Use of a lysate of bifidobacterium species for treating sensitive skin |
| 03/12/2009 | US20090068158 Thymidylate kinase mutants and uses thereof |
| 03/12/2009 | US20090068157 Derivation of unlimited quantities of neutrophils on monocyte/dendritic cells |
| 03/12/2009 | US20090068156 Treatment of muscular dystrophy with cord blood cells |
| 03/12/2009 | US20090068154 Cell Composition for Transplant |
| 03/12/2009 | US20090068153 Cell composition for tissue regeneration |
| 03/12/2009 | US20090068151 Methods and reagents for the enhancement of virus transduction in the bladder epithelium |
| 03/12/2009 | US20090068149 Use of a Fermented Milk Containing L. Casei for the Manufacture of a Composition for the Prevention or Treatment of a Delayed-Type Hypersensitivity Reaction |
| 03/12/2009 | US20090068148 Peptides of cav2.2 that inhibit pain |
| 03/12/2009 | US20090068141 Autologous natural killer cells and lymphodepleting chemotherapy for the treatment of cancer |
| 03/12/2009 | US20090068139 LOOP PEPTIDE AND TGF alpha FOR STIMULATING STEM CELL PROLIFERATION AND MIGRATION |
| 03/12/2009 | US20090068121 Lantibiotics and uses thereof |
| 03/12/2009 | DE102007042176A1 Orally administered antidiabetic composition, effective against type 1 and type 2 diabetes, is obtained by electrolysis of drinking water containing added potassium and manganese salts |
| 03/12/2009 | CA2711425A1 Antimicrobial activity of bacteriocin-producing lactic acid bacteria |
| 03/12/2009 | CA2704730A1 Cell composition for tissue regeneration |
| 03/12/2009 | CA2698988A1 Composition for separating spermatozoa from a semen sample |
| 03/12/2009 | CA2698661A1 Method to ameliorate oxidative stress and improve working memory via pterostilbene administration |
| 03/12/2009 | CA2698514A1 Methods of treating or preventing respiratory tract infection comprising administering cholecalciferol |
| 03/12/2009 | CA2698011A1 Porcine adeno-associated viruses |
| 03/12/2009 | CA2697735A1 Use of a combination of hesperidin and of a microorganism for influencing the barrier function of the skin |
| 03/12/2009 | CA2697518A1 A feeder cell-free culture medium and system |
| 03/11/2009 | EP2034014A1 Therapeutic agent for alzheimer's disease |
| 03/11/2009 | EP2034009A2 Compositions and methods for restoring immune responsiveness in patients with immunological defects basing on cd3/cd28 costimulation |
| 03/11/2009 | EP2033972A1 Screening method for candidate drugs |
| 03/11/2009 | EP2033651A1 Oxalate-degrading microorganisms or oxalate-degrading enzymes for preventing oxalate related disease |
| 03/11/2009 | EP2033529A2 Synbiotic composition for infants |
| 03/11/2009 | EP2032687A1 Salmonella enterica strains of reduced pathogenicity, method for their preparation and uses thereof |
| 03/11/2009 | EP2032148A2 Composition containing lactobacillus sp. and a cannabinoid receptor and/or a opioid receptor agonist |
| 03/11/2009 | EP2032147A1 Cox-2 inhibitor |
| 03/11/2009 | EP2032122A2 Extracts of aphanizomenon flos aquae and nutritional, cosmetic and pharmaceutical compositions containing the same |
| 03/11/2009 | EP1931216B1 Immunoglobulin and fatty acids |
| 03/11/2009 | EP1888099A4 Hydratable keratin compositions |
| 03/11/2009 | EP1305409B1 Renal regulatory elements and methods of use thereof |
| 03/11/2009 | EP1206523B1 Bifidobacteria preventing diarrhea caused by pathogenic bacteria |
| 03/11/2009 | EP1071763B1 Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group b streptococcal carbohydrates |
| 03/11/2009 | CN101384722A 疫苗组合物 Vaccine compositions |
| 03/11/2009 | CN101384716A Hla-a*3303-restricted wt1 peptide and pharmaceutical composition comprising the same |
| 03/11/2009 | CN101384714A Novel viral vector |
| 03/11/2009 | CN101384707A A method for osteogenic differentiation of bone marrow stem cells (BMSC) and uses thereof |
| 03/11/2009 | CN101384706A Skeletal muscle periangioblasts and cardiac mesangioblasts, method for isolation and uses thereof |
| 03/11/2009 | CN101384704A Resorbable cornea button |
| 03/11/2009 | CN101384702A Mesenchymal stem cells and uses therefor |
| 03/11/2009 | CN101384700A Novel lactobacillus strains and their use against helicobacter pylori |
| 03/11/2009 | CN101384270A Control of intestinal inflammatory syndromes with a preparation of killed or non infectious bacteria |
| 03/11/2009 | CN101384269A Use of lactobacillus for treatment of virus infections |
| 03/11/2009 | CN101381668A Method for preparing health-care medicinal liquor |
| 03/11/2009 | CN101381667A Preparation method of pilose antler blood alcohol |
| 03/11/2009 | CN101381658A Anhydrous grape healthy wine |
| 03/11/2009 | CN101380465A Construction method of Beta-alexin-2-tumor vaccine and uses thereof |
| 03/11/2009 | CN101380459A Elderly dehumidification pain relieving ointment |
| 03/11/2009 | CN101380456A Traditional Chinese medicine for treating infantile bed-wetting |
| 03/11/2009 | CN101380455A Formulation for treating apoplexy |
| 03/11/2009 | CN101380454A Formulation for treating apoplexy |
| 03/11/2009 | CN101380453A Oral powder and external plaster for treating hyperosteogeny and atrophic arthritis and production method thereof |
| 03/11/2009 | CN101380446A Formulation for treating apoplexy |
| 03/11/2009 | CN101380445A Formulation for treating apoplexy |
| 03/11/2009 | CN101380444A Formulation for treating apoplexy |
| 03/11/2009 | CN101380443A Cooling decoction |
| 03/11/2009 | CN101380442A Agent for treating tummy bug and duodenum ulcer |
| 03/11/2009 | CN101380440A Use of Yunkang oral liquid in preparing medicine for treating kidney-deficiency type sterility |
| 03/11/2009 | CN101380438A Medicine composition for treating palsy hemiplegia due to cardiac and cerebral vessels and preparation method thereof |
| 03/11/2009 | CN101380437A Medicine for treating hysteromyoma |
| 03/11/2009 | CN101380435A Formulation for treating apoplexy |
| 03/11/2009 | CN101380432A Oral liquid for clearing warm and counteracting a toxin |